These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus. Agrawal A; Narayan G; Gogoi R; Thummer RP Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962 [TBL] [Abstract][Full Text] [Related]
24. How to make insulin-producing pancreatic β cells for diabetes treatment. Lu J; Xia Q; Zhou Q Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637 [TBL] [Abstract][Full Text] [Related]
25. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360 [TBL] [Abstract][Full Text] [Related]
26. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes. Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899 [TBL] [Abstract][Full Text] [Related]
27. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice. Ho JH; Tseng TC; Ma WH; Ong WK; Chen YF; Chen MH; Lin MW; Hong CY; Lee OK Cell Transplant; 2012; 21(5):997-1009. PubMed ID: 22004871 [TBL] [Abstract][Full Text] [Related]
33. Adult mesenchymal stem cells and their potency in the cell-based therapy. Das M; Sundell IB; Koka PS J Stem Cells; 2013; 8(1):1-16. PubMed ID: 24459809 [TBL] [Abstract][Full Text] [Related]
34. An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy. Pavathuparambil Abdul Manaph N; Sivanathan KN; Nitschke J; Zhou XF; Coates PT; Drogemuller CJ Stem Cell Res Ther; 2019 Sep; 10(1):293. PubMed ID: 31547868 [TBL] [Abstract][Full Text] [Related]
35. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991 [TBL] [Abstract][Full Text] [Related]
38. Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration. Ghoneim MA; Gabr MM; El-Halawani SM; Refaie AF Stem Cell Res Ther; 2024 Jan; 15(1):23. PubMed ID: 38281991 [TBL] [Abstract][Full Text] [Related]
39. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. Kim SJ; Choi YS; Ko ES; Lim SM; Lee CW; Kim DI J Biosci Bioeng; 2012 Jun; 113(6):771-7. PubMed ID: 22425523 [TBL] [Abstract][Full Text] [Related]
40. Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene. Pellegrini S; Pipitone GB; Cospito A; Manenti F; Poggi G; Lombardo MT; Nano R; Martino G; Ferrari M; Carrera P; Sordi V; Piemonti L J Clin Endocrinol Metab; 2021 Apr; 106(5):e2322-e2333. PubMed ID: 33417713 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]